H1B Salary Data

Home › Employers › Agrace HospiceCare, Inc.

Agrace HospiceCare, Inc.: H-1B salaries and sponsorship

Agrace HospiceCare, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $65,000.

Applications (LCAs)3
Certified3
Employer addressMadison, WI
H-1B dependent employerNo
Median offered salary$65,000
Middle half of salaries$65,000–$80,000
10th–90th percentile$65,000–$89,000

Does Agrace HospiceCare, Inc. sponsor H-1B visas?

Agrace HospiceCare, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 23, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Business Intelligence Developer1$65,000
Business Intelligence & Data Specialist1$65,000
IT Applications Specialist1$95,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20243$65,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
IT Applications Specialist$95,000–$115,000
Level II
Madison, WISep 23, 2024Jan 3, 2025Certified
Business Intelligence Developer$65,000–$85,000
Level II
Madison, WIMay 14, 2024Oct 1, 2024Certified
Business Intelligence & Data Specialist$65,000–$85,000
Level II
Madison, WIApr 22, 2024Oct 1, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).